Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma
Titel:
Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma
Auteur:
Jurczak, W. Zinzani, P.L. Gaidano, G. Goy, A. Provencio, M. Nagy, Z. Robak, T. Maddocks, K. Buske, C. Ambarkhane, S. Winderlich, M. Dirnberger-Hertweck, M. Korolkiewicz, R. Blum, K.A.